Home
Sirenia Capital Management reported a 9.5% stake in Design Therapeutics DSGN · 5,963,936 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 9.5%
- Last report
- First report
- Shares held
- 5,963,936 sh
- Class
- Common Stock, par value $0.0001 per share
- Event date
- 26/06/30
- Filed
- 26/08/14
First 5%+ report · 9.5% stake
Design Therapeutics trades, last 26 weeks
What else happened in Design Therapeutics around then
Filed or reported within 30 days of the trade day · 05/31~07/30Sirenia Capital Management's other 5% stake reports
- Sirenia Capital Management
5% stakeTraws Pharma
5% stakeTraws Pharma
TRAW
9.9% stake
6,565,474 sh
9.9% stake
Filed 08/14
- Sirenia Capital Management
5% stakeTonix Pharmaceuticals Holding
5% stakeTonix Pharmaceuticals Holding
TNXP
4.9% stake
814,801 sh
4.9% stake
Filed 08/14
- Sirenia Capital Management
5% stakeQ32 Bio
5% stakeQ32 Bio
QTTB
0% stake
0 sh
0% stake
Filed 08/14
- Sirenia Capital Management
5% stakeInflaRx
5% stakeInflaRx
IFRX
6.1% stake
8,911,348 sh
6.1% stake
Filed 08/14
- Sirenia Capital Management
5% stakeImmunome
5% stakeImmunome
IMNM
4.3% stake
4,832,279 sh
4.3% stake
Filed 08/14
